glycyrrhizic acid has been researched along with endothelin-1 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lüscher, TF; Quaschning, T; Ruschitzka, F; Shaw, S | 1 |
| deGottardi, A; Enseleit, F; Hürlimann, D; Lüscher, TF; Noll, G; Quaschning, T; Rossier, MF; Ruschitzka, F; Shaw, SG | 1 |
| Lyakhovich, VV; Makarova, SI; Nikitin, YP; Ragino, YI; Safronova, OG; Salakhutdinov, NF; Stakhneva, EM; Tolstikov, GA; Vavilin, VA | 1 |
| Biasibetti, R; Bobermin, L; de Souza, DF; Galland, F; Gonçalves, CA; Gottfried, C; Guerra, MC; Leite, MC | 1 |
| Chang, HJ; Kang, WJ; Kim, DH; Lee, SE; Lee, YJ; Shin, JS; Yang, PS | 1 |
5 other study(ies) available for glycyrrhizic acid and endothelin-1
| Article | Year |
|---|---|
Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Aorta; Blood Pressure; Body Weight; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Eplerenone; Glycyrrhiza; Glycyrrhizic Acid; Heart Rate; Hydroxysteroid Dehydrogenases; Hypertension; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Molecular Structure; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Plants, Medicinal; Rats; Rats, Inbred WKY; Spironolactone; Vasodilation | 2001 |
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Acetylcholine; Animals; Blood Pressure; Body Weight; Cells, Cultured; Corticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endothelium, Vascular; Gene Expression Regulation; Glycyrrhizic Acid; Heart Rate; Humans; Hydroxysteroid Dehydrogenases; Hypertension; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Phenylpropionates; Potassium Chloride; Protein Precursors; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Vascular Diseases; Vasoconstriction; Vasodilation; Vasodilator Agents; Verapamil | 2001 |
Antioxidant and endothelium-stabilizing effects of simvaglyzin on rabbits with experimental hypercholesterolemia.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Antioxidants; Aryldialkylphosphatase; Cholesterol; Diet; Endothelin-1; Endothelium, Vascular; Fluorometry; Glycyrrhizic Acid; Hypercholesterolemia; Male; Nitrous Oxide; Rabbits; Simvastatin; von Willebrand Factor | 2008 |
Gap junction inhibitors modulate S100B secretion in astrocyte cultures and acute hippocampal slices.
Topics: Animals; Astrocytes; Carbenoxolone; Cell Line, Tumor; Central Nervous System Agents; Endothelin-1; Flufenamic Acid; Gap Junctions; Glycyrrhizic Acid; Halothane; Hippocampus; Humans; In Vitro Techniques; Nerve Growth Factors; Octanols; Rats; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors | 2009 |
Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Glycyrrhizic Acid; HMGB1 Protein; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Muscle, Smooth, Vascular; Pneumonia; Pulmonary Artery; Rats, Sprague-Dawley; Time Factors; Vascular Remodeling; Ventricular Dysfunction, Right; Ventricular Function, Right | 2014 |